er children, regarding whether temporal arachnoid cysts (TACs) tend to grow. Al-Holou et al. 1 found that more than 90% of TACs remained stable with no cases of cyst enlargement, new symptoms, or surgery performed in those patients who are 4 years and older.
Cognitive and behavioral deficits associated with TAC have been suggested, but the findings have not been definitive. Head CT performed in 76 children with mental retardation found only 2 children with arachnoid cysts, a prevalence similar to that of the general population. 22 Lang et al. first reported disturbances of higher cognitive processes in a case series of 10 adults with TAC and frontal arachnoid cyst. 20 Subsequently, multiple studies performed by a Norwegian group found several neuropsychological deficits in adults with TAC that resolved with surgery. 8, 12, 17, 27, 32, 37, 38 Another group reported improvement in language skills in adults after surgery. 21 In contrast, Rabiei et al. 26 found no association between arachnoid cysts and cognitive impairment. Spansdahl and Solheim 29 found that anxiety scores were 3 times higher than normal in adults with TAC, with no significant differences between operated and nonoperated patients.
In the only pediatric study to date that assessed cognitive and neuropsychological function in patients with arachnoid cysts, Park et al. 25 found no significant differences between the study and control groups in terms of verbal, performance, or full-scale IQ. No adverse group differences were found in the arachnoid cyst group regarding executive function, inattention, and impulsivity, but the authors noted that 35.7% of patients were outside of the normal range for inattention and 39.7% of patients were outside of the normal range for impulsivity. Similarly, no significant negative differences were seen for depression or anxiety symptoms. The 20 patients who underwent surgery for arachnoid cyst did not show significant differences in intelligence, memory, or anxiety compared with the rest of the population.
In summary, data regarding neurodevelopmental deficits due to TACs and whether they serve as an indication for surgery remain mixed. Thus, the clinician is limited in making recommendations. The aim of this study was to examine neurodevelopmental outcome in children with Galassi type II or III TAC.
Methods

Participants
This study included a convenience sample of patients with TAC (age range 2-20 years) who presented during the pediatric period with a Galassi type II or III TAC to the Pediatric Neurology Unit or Pediatric Neurosurgery Department at Dana Children's Hospital, Tel Aviv Medical Center. The sibling with the closest age to each patient served as the control participant. Patients were included if they completed at least 1 of the study questionnaires. For the purposes of this study, classification was based on size (Galassi type I, II, and III) and not dysmorphology. Therefore, for this study, a patient with cyst size consistent with type II but with a skull protuberance above the cyst area was considered to have a Galassi type II cyst.
Measures
The following questionnaires were completed by parents and used as proxies for measuring neurodevelopmental function.
Adaptive Behavior Assessment System-2nd Edition
The Adaptive Behavior Assessment System (ABAS)-2nd Edition 14, 36 (Hebrew and Arabic versions; http:// www.psychtech.co.il/New/Products/ABASII) generates a general adaptive composite (GAC) score that summarizes performance across all skill areas, except for work, and a subscore for each of the 3 general areas of adaptive behavior as follows. The conceptual composite score summarizes performance across the communication, functional academics, and self-direction skill areas. The social composite score summarizes performance across the leisure and social skill areas. The practical composite score summarizes performance across community use, home living, health and safety, and self-care skill areas. The mean score is 100 with a 15-point standard deviation. This instrument has been used to assess individuals with intellectual disability, learning difficulties, and attentiondeficit/hyperactivity disorder. In this study, we used the parent version.
Vanderbilt Behavioral Rating Scale
Vanderbilt Behavioral Rating Scale (VBRS) is a behavioral rating scale based on the Diagnostic and Statistical Manual, Fourth Edition criteria for attention-deficit/ hyperactivity disorder, oppositional defiant disorder, and conduct disorder. In addition, VBRS includes screens for mood and anxiety symptoms and a rating of child performance. The parent form 3 has 55 items that comprise 6 subsections: attention (items 1-9), hyperactivity-impulsivity (10-18), oppositional defiant disorder (19) (20) (21) (22) (23) (24) (25) (26) , conduct disorder (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) , and anxiety and depression (41-47). Symptoms are rated using a 0-3 scale where a positive response is a score of 2 or 3 (often and very often, respectively) that reflects problematic behavior. Overall function (48-55) is rated using a 1-5 scale where a positive response is a score of 4 or 5 that reflects problems in performance. Subscores are generated for each of the subsections. A total score and mean total score were generated by summing or averaging all of the symptom items . This instrument was administered using either the Hebrew or Arabic translation, as appropriate.
Developmental Coordination Disorder Questionnaire
The Developmental Coordination Disorder Questionnaire (DCDQ; Hebrew version) is a parent-completed measure designed to identify subtle motor problems in children that are formally known as developmental coordination disorders. 28, 33, 39 The DCDQ consists of 15 items that include everyday activities (e.g., catching a ball) that children can typically perform. These items are grouped into 3 distinct factors: control during movement, fine motor and handwriting, and general coordination. The total score ranges from 15 to 75 (a higher score indicates better motor coordination) and suggests the presence, risk, or absence of developmental coordination disorder. The validity and reliability of the previous Hebrew version of DCDQ were demonstrated for school-aged children in Israel.
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Treatment-Oriented Screening Questionnaire
The presence of physical, cognitive, and/or behavioral deficits and their effects on quality of life (QOL) due to TAC were measured using the treatment-oriented screening questionnaire (TOSQ).
11 TOSQ measures late effects and identifies specific deficits in survivors of pediatric brain tumors. This questionnaire was designed for patients who are 6-18 years of age. In this study, we used the parent version. Each potential late effect is examined using items that provide an objective assessment of the symptom's severity and a subjective assessment of the symptom's influence on the individual's QOL. The output of TOSQ consists of 12 scores in the areas of endocrinology, neurology, neurosurgery, occupational therapy, ophthalmology, pain therapy, physiotherapy, psychology, sleep therapy, social work, special education, and speech therapy. Most items are scored using a 5-point Likert scale, and each area score is a weighted average of the individual questions in that subsection. Thus, the TOSQ results reflect the patient's health status in the areas examined, with a higher score suggesting more difficulties.
Procedures
The parents of the children who met the inclusion criteria were provided an explanation of the study. Eightynine percent (25 patients) of parents approached agreed to participate. Clinical data were retrieved from the medical records. Cyst location and Galassi type were verified by a senior neurosurgeon (J.R.) based on the most recent findings on MRI for those with no intervention or on the presurgical MRI for those who underwent intervention. We obtained neurodevelopmental information about the patients during the years 2014-2016, using questionnaires as follows: for the identified patient, the parent completed the appropriate ABAS as well as VBRS, DCDQ, and TOSQ. The patient's sibling who was closest in age served as the sibling control participant and for whom the parents completed the appropriate ABAS, VBRS, and DCDQ assessments.
This study was approved by the medical center's review board, and fully informed consent was obtained from the parents. The statistical analysis was performed using IBM SPSS Statistics for Windows (version 23.0, IBM Corp.).
Statistical Analysis
Descriptive statistics were used for the categorical variables. Parametric tests were used when at least 30 participants, or at least 15 pairs of participants, completed a certain outcome measure; otherwise, nonparametric tests were conducted. 23 To determine differences between the patients and sibling controls on ABAS, VBRS, and DCDQ scores, the paired-sample t-test or its nonparametric equivalent, the Wilcoxon signed-rank test, was used for all subsections and percentile rankings where applicable. Pearson's or Spearman's correlation coefficients were calculated to determine the differences between these measures in the patients and sibling control participants. To examine the differences between the operated and nonoperated subgroups and for subgroups with different cyst characteristics (right vs left, Galassi type II vs III, frontotemporal vs temporal), the Mann-Whitney U-test or independent samples t-test was performed on the ABAS, VBRS, DCDQ, and TOSQ scores. For dichotomous items, the chi-square test was performed. When statistical power was calculated, this was in accordance with a 2-tailed test.
Results
The study group consisted of 25 patients with Galassi type II or III TAC. See Fig. 1 for representative images of Galassi type II and III cysts in our cohort. We obtained data about the sibling control participants for 21 of these patients. Table 1 presents clinical information for the patients with TAC. Symptom presentation varied, and many patients had multiple symptoms. The majority of the cysts (64%) were Galassi type III. Table 2 provides information for those patients who underwent surgery for the cyst. The indications for surgery and the type of intervention were at the discretion of the surgeon, with more than 1 surgeon managing patients in this cohort.
Demographic information regarding the groups is pre- sented in Table 3 . The age at presentation for all patients with cysts was in the pediatric period, with a majority of patients presenting from the antenatal to preschool period. Male patients predominated in the cohort (76%). The distributions of mean age, sex, and ethnicity did not differ significantly between the patient and sibling control groups. Not all patients completed all questionnaires, thus explaining the different numbers of patients included in the analyses of each of the different instruments (Supplementary Tables 1 and 2 ). Table 4 presents the overall GAC score and subscores of the ABAS questionnaire for the cyst group and the sibling control group. Figure 2 presents the actual GAC scores. Questionnaires were obtained from 20 complete pairs, and 3 additional patients with cysts but without a sibling control participant completed ABAS. The patient and sibling control groups had a 5-point difference in the GAC score that favored the sibling control participants. However, this difference did not reach statistical significance. Effect sizes were weak, thereby indicating that the group means did not substantially differ regardless of the small sample size. Patients with cysts and their sibling control participants were significantly similar with respect to the overall ABAS scores (GAC) and all 3 major subscores. When the analyses were performed in a dichotomous manner-by comparing poor outcome (defined as an ABAS GAC score less than 80) to good outcomethere was a trend for more patients with cysts to have a poor outcome than the sibling control participants (7 of 20 vs 2 of 20; p = 0.058). We were not able to identify any characteristic on ABAS that identified this subgroup of patients with poor outcome.
Adaptive Behavioral Assessment System
Comparison of the overall score (GAC) and the 3 subscores revealed no significant differences between operated versus nonoperated patients, Galassi type II versus type III cysts, right-versus left-sided cysts, or frontotemporal versus temporal involvement. Table 5 presents the mean VBRS scores of the patient and sibling control groups. Fourteen complete pairs were obtained, and an additional 6 patients with cysts but without a sibling control participant completed the instrument. No significant differences in the total scores or subscores were found between the patients with cysts and the sibling control participants. Despite the limited power of the small sample, the weak effect sizes of these comparisons suggest that a larger sample size with similar mean values would not have reached statistical significance either.
Vanderbilt Behavior Rating Scale
We found that those patients who underwent surgery had significantly higher mean values on the anxiety and depression subsection (i.e., worse function) than those patients who did not undergo surgery (p < 0.027). No significant differences were noted on VBRS between patients with Galassi type II versus type III cysts, right-versus left-sided cysts, or frontotemporal versus only temporal involvement. The lack of baseline VBRS data prevented assessment of whether the behavioral changes noted on VBRS were a result of undergoing a CNS surgical procedure. Table 6 includes the mean scores and the 3 subscores of the DCDQ for patients with cysts and the sibling control participants. Thirteen complete pairs were obtained, and an additional 3 patients with a cyst but without a sibling control participant completed the instrument. No significant differences were found between the patients and their siblings on the DCDQ subscores or total score. As with previous measures, the effect sizes were weak, thereby indicating a low magnitude of difference between the scores of the patients with cysts and the sibling control participants. No significant differences were found between the operated versus nonoperated subgroups or the left-versus right-sided cyst subgroups. The sample size was insufficient to assess differences in the subgroups of patients with Galassi type II versus type III cysts or frontal versus frontotemporal cysts.
Developmental Coordination Disorder Questionnaire
Treatment-Oriented Screening Questionnaire
The mean total group scores on TOSQ for those patients with TAC who underwent surgery (90.75 ± 18.53) versus nonoperated patients (91.25 ± 24.86) were not statistically different. The mean group scores for the individual items did not differ between these groups either.
We performed a more detailed examination of the items on TOSQ by looking at the mean scores of each of the individual items and then grouping them into physical or cognitive and psychological items (Fig. 3) . The mean score of the cognitive and psychological items (1.86) was significantly more negatively affected than the mean score of the physical items (1.13) (Wilcoxon Z-score = -4.29, p < 0.001). In contrast, there were no differences in the individual items between the operated versus nonoperated subgroups, nor were there any differences between right-versus left-sided cysts, Galassi type II versus type III cysts, or temporal versus frontotemporal cysts.
Ninety-two percent of parents reported that their child with a TAC had excellent to good health status, 88% reported that their child was very satisfied or satisfied with their QOL, and 96% reported that their child's QOL was excellent to good. Based on the parent reports, 8% of the cohort had a confirmed learning disability, 28% had a suspected learning disability, and 64% had no learning disability.
Discussion
This is the first study to focus on neurodevelopmental outcomes in patients with pediatric Galassi type II and III TACs. We found no significant group differences between children with a large TAC and their sibling control participants, though further analysis found a trend that suggested that a minority of such children have abnormal neurodevelopment as manifested by abnormal adaptive function. In contrast, most patients with a large TAC had function that was normal or above normal. More focused measures of behavior and motor coordination did not reveal any group differences. We also found that more than 95% of our cohort with cysts reported QOL to be good or better with no difference between those who did and did not undergo surgery for the cyst. Thus, we can state that having a large TAC does not preclude satisfactory QOL. Because we did not have presurgical QOL data on those who underwent surgery, we are unable to make a statement regarding the value of surgery on later QOL outcome. Interestingly, the cognitive and psychological items on TOSQ were noted to be significantly more negatively affected than the physical items.
Temporal cyst location and its possible effect on the areas involved in cognitive function may explain this finding. Our findings further buttress the position that a large TAC can be managed conservatively, 4 notwithstanding indications that suggest otherwise, such as increased intracranial pressure. We suggest that our data support using baseline and ongoing neurodevelopmental assessments as a standard part of the ongoing care of children with a large TAC because a demonstration of normal function would support a conservative approach.
Our finding of a pediatric subgroup with affected neurodevelopment stands in contrast to both the unequivocal negative effects on neurodevelopment reported in patients with arachnoid cysts by numerous studies performed by a Norwegian group 8, 12, 17, 27, 32, 37, 38 and the report by Rabiei et al., 26 which found no correlation between negative cognitive effects and arachnoid cysts. Both groups differed from our study in that they examined adult cohorts with various types and grades of arachnoid cysts.
In contrast, and of greater relevance, our findings are generally consistent with the only other pediatric study of neuropsychological function in children with arachnoid cysts in the literature, 25 which found no significantly adverse neuropsychological effects in children with cysts versus controls. However, that study differed from ours in both population and design. The study had a similarly sized but more varied group, with only 54% of the cohort having Galassi type II or III TACs. The study also used a combination of direct measures and questionnaires with clinical nonsibling control participants versus our study, which used more robust sibling control participants.
Finally, in contrast to the study that examined QOL in adults with arachnoid cysts, 29 our findings are more optimistic, with 96% of our patients reporting good or better QOL. Again, the differences between these 2 studies, including patient age and TAC size, limit a more complete comparison.
A notable minority of our cohort functioned above average on ABAS, a measure of adaptive function, despite the significant loss of space or significant compression of the brain parenchyma. There is a precedent for this in the literature, though it is supported only by case reports. 4-6, 9, 16,24 Understanding this phenomenon may shed light on the more salient aspects underlying intact cognitive function.
Functional MRI data from an asymptomatic patient, whose extensive, frontal arachnoid cyst was found incidentally, showed notable changes from the normal pattern of activation seen in the cortical and cerebellar areas that could not be accounted for by the space-occupying effect of the cyst alone. 2 The authors suggested that these findings demonstrate an alternative organization of the central motor system with preserved neurological function. Thus, we have a possible explanation for preserved cognitive function in the presence of a large TAC. Perhaps in cases in which cognitive function is impaired, consideration should be given to approaches that influence alternative CNS organization via the use of neuromodulation.
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Study Limitations
The limitations of this study include the small sample size and the heterogeneity of the study group, which included patients who underwent surgery versus those who did not, patients with increasing cyst size versus radiographically stable cysts, and patients with various ages at the time of assessment. All of these heterogeneities limit the external validity of our findings. However, all of these limitations reflect the rarity of the specific arachnoid cyst type examined and the logistical issues of obtaining a pediatric cohort. Furthermore, we examined the effect sizes of our findings and found them to be weak, thereby suggesting that the group mean values did not substantially differ regardless of the relatively small sample size.
Another limitation is that standardized questionnaires were employed as a proxy for direct neurodevelopment assessment. However, standardized questionnaires are valid and useful outcome measures. 13, 18 Furthermore, our study has the advantage of providing functional and QOL data that have not been reported to date in a pediatric cohort with TAC. Both functional and QOL data are crucial elements for determining management 30, 35 and provide a measure of ecological validity to our assessment. The use of sibling control participants is another significant strength of this study because it addresses many confounders associated with family and socioeconomic influences. Furthermore, this is the only study to date that focuses solely on large TACs, which now present the most pressing dilemma for clinicians. Finally, the lack of presurgical testing did not allow assessment of the effect of surgery.
Conclusions
We have shown that children with large TACs perform similarly to sibling control participants, although a subgroup with low ABAS scores had an increased risk of poor outcomes in general function. These findings support the use of neurodevelopmental assessment as an integral part of the management for all patients with TAC. Future prospective studies of this condition are warranted.
